Duligotuzumab Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
ELEV | D | Elevation Oncology, Inc. | 4.15 | |
SLRN | F | Acelyrin Inc. | -2.26 |
Related Industries: Biotechnology
Related Stock Lists:
Clinical Medicine
Advanced Solid Tumors
Biopharmaceutical
Biotechnology
Cancer
Chronic Urticaria
Drugs
Health Sciences
Hidradenitis Suppurativa
Immunology
Life Sciences
Monoclonal Antibodies
Monoclonal Antibody
Pharmacy
Psoriatic Arthritis
Thyroid Eye Disease
Treatment Of Cancer
Uveitis
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
IWC | B | iShares Microcap ETF | 0.09 | |
VFMO | A | Vanguard U.S. Momentum Factor ETF | 0.04 | |
IBB | D | iShares Nasdaq Biotechnology Index Fund | 0.04 | |
IWN | B | iShares Russell 2000 Value ETF | 0.03 | |
IWM | B | iShares Russell 2000 ETF | 0.02 |
Compare ETFs
Related Industries:
Biotechnology
Related Stock Lists:
Clinical Medicine
Advanced Solid Tumors
Biopharmaceutical
Biotechnology
Cancer
Chronic Urticaria
Drugs
Health Sciences
Hidradenitis Suppurativa
Immunology
Life Sciences
Monoclonal Antibodies
Monoclonal Antibody
Pharmacy
Psoriatic Arthritis
Thyroid Eye Disease
Treatment Of Cancer
Uveitis
- Duligotuzumab
Duligotuzumab (INN) is a bispecific humanized IgG1 monoclonal antibody designed for the treatment of cancer. It acts as an immunomodulator and binds to EGFR and HER3. It is in development by Roche. Clinical development for head and neck cancer and colorectal cancer have been discontinued, but phase I trials in combination with cobimetinib are evaluating safety for treatment of solid tumors.
Popular Now
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles